在骨髓瘤患者的风险分层系统与自身干细胞移植
Wancheng Guo1,2, Christopher Strouse3, David Mery1
1Myeloma Center, Department of Internal Medicine, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, 4301 W. Markham St. Slot# 508, Little Rock, AR 72205, USA.
Cancers
|March 28, 2024
概括
这项研究确定了影响多发性骨髓瘤 (MM) 患者在自身干细胞移植 (ASCT) 后结果的关键因素. 一个新的分期系统 (ATM4S) 使用这些因素来预测预后和个性化MM治疗.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床研究 临床研究
背景情况:
- 自主干细胞移植 (ASCT) 是多发性骨髓瘤 (MM) 的标准治疗方法.
- 在ASCT后的患者预后存在显著的变化.
- 现有的预后模型需要改进,以更好地分层患者.
研究的目的:
- 为了确定接受ASCT的MM患者的不良预后因素.
- 开发和验证一种新的分期系统 (ATM4S),用于预测ASCT后的预后.
- 探索ATM4S系统对个性化MM治疗的临床实用性.
主要方法:
- 对接受ASCT的5259名MM患者的回顾性分析.
- 对29个临床变量的单变量和多变量考克斯回归分析.
- 使用培训和独立数据集开发和验证ATM4S分期系统.
主要成果:
- 鉴定了从MM诊断到ASCT的延长时间,高血清费里丁和降低的转激素作为关键的不良预后因素.
- 开发了ATM4S系统,使用七个高风险变量,在独立队列中验证.
- 在ATM4S框架内探索细胞遗传风险因素.
结论:
- ATM4S分期系统有效地根据ASCT后预后对MM患者进行分层.
- 纳入已识别的预后因素可以增强现有的MM治疗模式.
- 该ATM4S系统具有指导MM个性化治疗策略的潜力.
更多相关视频
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
06:28Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
Published on: November 10, 2023
2.0K
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Bone Marrow Sampling and Transplants
328
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
328
